Spruce Biosciences, Inc.
SPRB
$0.0801
-$0.0497-38.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.75M | 60.06M | 69.68M | 81.15M | 96.34M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.18M | 2.66M | 2.70M | 3.10M | 3.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.28M | 860.00K | 1.53M | 1.61M | 1.97M |
| Total Current Assets | 44.21M | 63.57M | 73.91M | 85.87M | 102.18M |
|
|
|||||
| Total Current Assets | 44.21M | 63.57M | 73.91M | 85.87M | 102.18M |
| Net Property, Plant & Equipment | 934.00K | 998.00K | 1.06M | 1.12M | 1.18M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 69.00K | 531.00K | 547.00K | 553.00K | 582.00K |
| Total Assets | 45.21M | 65.10M | 75.52M | 87.54M | 103.95M |
|
|
|||||
| Total Accounts Payable | 1.30M | 1.80M | 682.00K | 1.89M | 3.33M |
| Total Accrued Expenses | 12.05M | 7.47M | 10.42M | 11.71M | 14.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.91M | 1.90M | 1.89M | 1.88M | 1.87M |
| Total Finance Division Other Current Liabilities | -- | 697.00K | 1.30M | 2.91M | 4.91M |
| Total Other Current Liabilities | -- | 697.00K | 1.30M | 2.91M | 4.91M |
| Total Current Liabilities | 15.25M | 11.86M | 14.29M | 18.39M | 24.47M |
|
|
|||||
| Total Current Liabilities | 15.25M | 11.86M | 14.29M | 18.39M | 24.47M |
| Long-Term Debt | 124.00K | 524.00K | 923.00K | 1.32M | 1.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 736.00K | 809.00K | 880.00K | 950.00K | 1.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 282.00K | 273.00K | 262.00K | 250.00K | 236.00K |
| Total Liabilities | 16.39M | 13.46M | 16.35M | 20.92M | 27.44M |
|
|
|||||
| Common Stock & APIC | 279.09M | 278.35M | 277.21M | 275.48M | 273.74M |
| Retained Earnings | -250.27M | -226.71M | -218.04M | -208.86M | -197.23M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 28.82M | 51.64M | 59.17M | 66.62M | 76.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.82M | 51.64M | 59.17M | 66.62M | 76.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.82M | 51.64M | 59.17M | 66.62M | 76.51M |
|
|
|||||